ID

4848

Description

see http://clinicaltrials.gov/ct2/show/study/NCT00048295 ISIS 2302 is an antisense oligonucleotide drug that reduces the production of a specific protein called intercellular adhesion molecule (ICAM-1), a substance that plays a significant role in the increase of inflammation. People with Crohn’s disease have been shown to over-produce ICAM-1 in their gut tissues. Alicaforsen works by blocking ICAM-1 messenger RNA, the “instruction” molecule that is required for the production of ICAM-1 protein. This trial will examine effects of alicaforsen delivered by 2-hour intravenous infusion over a four-week period, compared to a placebo. Patients may remain on stable background 5-ASA, antibiotic, or immunosuppressive drugs, and prednisone (or equivalent) at </= 30 mg per day.

Link

http://clinicaltrials.gov/ct2/show/study/NCT00048295

Keywords

  1. 4/11/14 4/11/14 - Julian Varghese
Uploaded on

April 11, 2014

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00048295 Crohns Disease

Eligibility NCT00048295

  1. StudyEvent: Eligibility
    1. Eligibility NCT00048295
Inclusion
Description

Inclusion

Age at least 12 years
Description

Age

Data type

integer

Measurement units
  • [years]
Alias
UMLS CUI-1
C0001779
[years]
Weight at least 36 kg
Description

Weight

Data type

boolean

Alias
UMLS CUI-1
C0005910
CDAI score of 220 - 400
Description

CDAI score

Data type

boolean

Alias
UMLS CUI-1
C0451071
Documentation of Crohns disease activity by endoscopy, biopsy or imaging in the last 2 years
Description

Active Crohns disease

Data type

boolean

Alias
UMLS CUI-1
C0010346
No TNF-alpha inhibitor treatment for three months prior to first study drug infusion
Description

No TNF-alpha inhibitor

Data type

boolean

Alias
UMLS CUI-1
C1518422
UMLS CUI-2
C1456820
UMLS CUI-3
C0021469
Exclusion
Description

Exclusion

Known severe, fixed, symptomatic stenosis of the small or large intestine with significant dilation
Description

Severe intestinal stenosis

Data type

boolean

Alias
UMLS CUI-1
C0521587
Extensive external fistulization (> 3 external fistulae which are expressible with gentle compression); colostomy or ileostomy
Description

External fistulization

Data type

boolean

Alias
UMLS CUI-1
C0016169
Active infection, including infectious colitis, or infection with HIV, Hepatitis B or Hepatitis C
Description

Infection

Data type

boolean

Alias
UMLS CUI-1
C0009450
Malignancy within 3 years or poorly controlled medical illness
Description

Malignancy

Data type

boolean

Alias
UMLS CUI-1
C0006826
Requires intravenous heparin therapy or with a history of a bleeding problem
Description

Bleeding problem

Data type

boolean

Alias
UMLS CUI-1
C0005779

Similar models

Eligibility NCT00048295

  1. StudyEvent: Eligibility
    1. Eligibility NCT00048295
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion
Age
Item
Age at least 12 years
integer
C0001779 (UMLS CUI-1)
Weight
Item
Weight at least 36 kg
boolean
C0005910 (UMLS CUI-1)
CDAI score
Item
CDAI score of 220 - 400
boolean
C0451071 (UMLS CUI-1)
Active Crohns disease
Item
Documentation of Crohns disease activity by endoscopy, biopsy or imaging in the last 2 years
boolean
C0010346 (UMLS CUI-1)
No TNF-alpha inhibitor
Item
No TNF-alpha inhibitor treatment for three months prior to first study drug infusion
boolean
C1518422 (UMLS CUI-1)
C1456820 (UMLS CUI-2)
C0021469 (UMLS CUI-3)
Item Group
Exclusion
Severe intestinal stenosis
Item
Known severe, fixed, symptomatic stenosis of the small or large intestine with significant dilation
boolean
C0521587 (UMLS CUI-1)
External fistulization
Item
Extensive external fistulization (> 3 external fistulae which are expressible with gentle compression); colostomy or ileostomy
boolean
C0016169 (UMLS CUI-1)
Infection
Item
Active infection, including infectious colitis, or infection with HIV, Hepatitis B or Hepatitis C
boolean
C0009450 (UMLS CUI-1)
Malignancy
Item
Malignancy within 3 years or poorly controlled medical illness
boolean
C0006826 (UMLS CUI-1)
Bleeding problem
Item
Requires intravenous heparin therapy or with a history of a bleeding problem
boolean
C0005779 (UMLS CUI-1)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial